Kenneth Cohen to Sirolimus
This is a "connection" page, showing publications Kenneth Cohen has written about Sirolimus.
Connection Strength
0.043
-
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas. Haematologica. 2022 07 01; 107(7):1608-1618.
Score: 0.043